Selected article for: "future study and study limitation"
Author: Felipe Soares; Aline Villavicencio; Michel Jose Anzanello; Flavio Sanson Fogliatto; Marco Idiart; Mark Stevenson
Title: A novel high specificity COVID-19 screening method based on simple blood exams and artificial intelligence
  • Document date: 2020_4_14
    • ID: 2s5xd1oc_58
    Snippet: A limitation of our study is that we were not capable of identifying with high certainty which blood exams contribute the most to the classification, due to the nature of our AI model framework. However, previous studies already identified that C reactive protein 21 , leukocytes 22, 23 , platelets 22 , and lymphocytes 24 are altered at different levels in COVID-19 patients. Thus, we envision for future research a detailed study of which blood exa.....
    Document: A limitation of our study is that we were not capable of identifying with high certainty which blood exams contribute the most to the classification, due to the nature of our AI model framework. However, previous studies already identified that C reactive protein 21 , leukocytes 22, 23 , platelets 22 , and lymphocytes 24 are altered at different levels in COVID-19 patients. Thus, we envision for future research a detailed study of which blood exams are more informative for differential diagnosis, as well as understanding how the SARS-CoV-2 virus alters blood components.

    Search related documents:
    Co phrase search for related documents
    • blood component and SARS virus: 1
    • blood exam and differential diagnosis: 1
    • detailed study and different level: 1, 2
    • detailed study and future research: 1, 2, 3, 4, 5, 6, 7
    • detailed study and model framework: 1, 2
    • detailed study and previous study: 1, 2, 3, 4, 5, 6
    • detailed study and reactive protein: 1, 2, 3, 4, 5
    • detailed study and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • different level and future research: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • different level and high certainty: 1, 2
    • different level and model framework: 1, 2, 3, 4, 5, 6, 7
    • different level and patient different level: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • different level and previous study: 1, 2, 3, 4
    • different level and reactive protein: 1, 2, 3, 4, 5, 6, 7
    • different level and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • differential diagnosis and model framework: 1, 2
    • differential diagnosis and previous study: 1
    • differential diagnosis and reactive protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • differential diagnosis and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16